IL17A and Dengue hemorrhagic fever: When we analyzed the patients according to clinical severity, we found that there were significant percentages of CD4+IL-17-producing cells in DHF patients (mean 1.9%, SD ± 0.9) compared to DF patients (mean 1.2%, SD ± 0.6) (p < 0.05) (Figure 6B).